our mission


Cancer is ubiquitous, deadly, and costly.

Almost every person in the world will be touched by cancer during their lifetime. This year, in the U.S. alone, more than 1.7 million people will be diagnosed with cancer, and we’ll spend $174 billion on cancer care.

Cancer is also extremely complex to treat.

No two cancers are the same. There are 200+ different types of cancer, each with many more different stages and subtypes. Seven lung cancer subtypes were discovered in 2016 alone.

The good news is that we’re making tremendous progress in treatment.

There are over 700 cancer drugs in late-staged development, which is up 60% from a year ago. All 14 of the new active substances identified in 2017 were targeted therapies, and more than half had breakthrough status.

But the technology doctors use to make decisions and manage care is decades behind, preventing them from fully taking advantage of these advances.

Legacy Electronic Health Record (EHR) systems were designed for billing and compliance, not decision support. Doctors spend half of their patient visits gathering information and entering it into the computer instead of in analysis and discussion with the patient.

Information is buried and hidden in EHR systems, and there’s no immediate feedback loop on what’s working and what’s not.

As a result, many patients aren’t getting the kind of personalized care that is actually possible and could impact their lives.

The future is already here — it’s just not evenly distributed.
— William Gibson

We can no longer accept the status quo. We need to fix this broken system as soon as possible, so patients can take advantage of innovations that could extend and improve the quality of their lives, right now.

That’s why we at Project Ronin are on a mission to transform cancer care.



Company Founders

Hodgson (1).png

Dave Hodgson


Former President, Oxeon Partners, Former CTO, One Medical Group, Former CTO, WellnessFX

Agus (1).png

Dr. David Agus

Practicing Oncologist

Founding Director and CEO, Lawrence J. Ellison Institute for Transformative Medicine of USC

Professor of Medicine and Engineering, University of Southern California

Chapman (1).png

Rowan Chapman, PhD

VP, Innovation, Johnson & Johnson

Co-founder at Evidation Health and Vineti Inc


Larry Ellison

Executive Chairman & CTO, Oracle Corporation